Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs149209614 | chr12:56723586 | A/G | 1.01E-7 | 177 | 25.35 | 29.13 | 0.8 | KM Plot |
PCPG | rs149241310 | chr12:56653560 | A/G | 1.09E-7 | 177 | 25.17 | 27.33 | 0.8 | KM Plot |
PCPG | rs149276116 | chr12:6592004 | C/CAGG | 0.000283 | 176 | 16.3 | 26.27 | 25.42 | KM Plot |
PCPG | rs149363279 | chr10:131951035 | TATATGTCTTGGG/T | 0 | 177 | 25.47 | 24.47 | 3.17 | KM Plot |
PCPG | rs149428725 | chr2:118538473 | T/C | 1.67E-5 | 177 | 24.85 | 30.33 | 11.65 | KM Plot |
PCPG | rs149456126 | chr17:74698598 | AAAG/A | 0.000168 | 176 | 25.97 | 21.1 | 13.5 | KM Plot |
PCPG | rs149462074 | chr2:242559840 | G/C | 3.01E-5 | 174 | 25.87 | 27.27 | 20.28 | KM Plot |
PCPG | rs149571649 | chr7:105148092 | T/G | 5.04E-5 | 178 | 20.17 | 28.95 | 2.28 | KM Plot |
PCPG | rs149682044 | chr16:88634316 | G/A | 0.000109 | 171 | 25.53 | 23.53 | 14.47 | KM Plot |
PCPG | rs149711377 | chr2:24319987 | T/C | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs149790528 | chr7:36173997 | CAT/C | 0.000433 | 177 | 25.6 | 24.6 | 14.37 | KM Plot |
PCPG | rs149890031 | chr7:105149260 | A/T | 5.04E-5 | 178 | 20.17 | 28.95 | 2.28 | KM Plot |
PCPG | rs149980726 | chr12:56656265 | G/A | 1.09E-7 | 177 | 25.17 | 27.33 | 0.8 | KM Plot |
PCPG | rs150045697 | chr7:105149419 | G/A | 5.04E-5 | 178 | 20.17 | 28.95 | 2.28 | KM Plot |
PCPG | rs150095604 | chr16:89801466 | C/CGGAGGT | 0.000194 | 174 | 25.87 | 20.28 | 36.37 | KM Plot |